Amgen
AMGN
#99
Rank
NZ$308.41 B
Marketcap
NZ$572.75
Share price
-3.02%
Change (1 day)
25.91%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

EPS for Amgen (AMGN)

EPS in 2025 (TTM): NZ$22.44

According to Amgen's latest financial reports the company's current EPS (TTM) is NZ$22.62. In 2024 the company made an earnings per share (EPS) of NZ$13.23 a decrease over its 2023 EPS that were of NZ$21.81.

EPS history for Amgen from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$22.4469.59%
2024NZ$13.23-39.33%
2023NZ$21.813.12%
2022NZ$21.1517.57%
2021NZ$17.99-16.38%
2020NZ$21.51-4.32%
2019NZ$22.482.05%
2018NZ$22.03382.51%
2017NZ$4.57-74.52%
2016NZ$17.9212.66%
2015NZ$15.9034.9%
2014NZ$11.790.74%
2013NZ$11.7020.36%
2012NZ$9.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.99-86.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.16-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.24-72.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.32-49.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.08-15.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.35-89.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.12-19.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.76-65.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.62 57.47%๐Ÿ‡บ๐Ÿ‡ธ USA